China National Accord Medicines Corporation Ltd.
000028.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.77B
Close$
Share Statistics
| Market cap | $12.77 Billion |
|---|---|
| Enterprise Value | $10.19 Billion |
| Dividend Yield | $0.62 (3.09%) |
| Earnings per Share | $2.04 |
| Beta | 0.17 |
| Outstanding Shares | 612,221,584 |
Return
| Return on Equity | 5.55% |
|---|---|
| Return on Assets | 2.17% |
| Return on Invested Capital | 7.20% |
Valuation & Multiples
| P/E Ratio | 10.62 |
|---|---|
| PEG | -187.17 |
| Price to Sales | 0.17 |
| Price to Book Ratio | 0.58 |
| Enterprise Value to Revenue | 0.14 |
| Enterprise Value to EBIT | 6.11 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 29, 2026
EPS Estimate
$0.53
Average shareholder expectationRevenue Estimate
$20.00 B
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$0.54
Average shareholder expectationRevenue Estimate
$18.71 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About China National Accord Medicines Corporation Ltd.
39,449 employees
CEO: Zhaoxiong Lin China National Accord Medicines Corporation Ltd. primarily focuses on the wholesale and retail distribution of a wide array of pharmaceutical and medical products. The company's extensive product offerings include traditional Chinese rem...